Cleared Abbreviated

K003638 - MOJAVE CATARACT EXTRACTION SYSTEM

K003638 is an FDA 510(k) clearance for MOJAVE CATARACT EXTRACTION SYSTEM, manufactured by Allergan, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Abbreviated 510(k) pathway after a 81-day FDA review.

K003638 · Allergan, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2001
Decision
81d
Days
Class 2
Risk

K003638 is an FDA 510(k) clearance for the MOJAVE CATARACT EXTRACTION SYSTEM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Allergan, Inc. (Irvine, US). The FDA issued a Cleared decision on February 13, 2001 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Allergan, Inc. devices

FDA 510(k) Submission Details - K003638

510(k) Number K003638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2000
Decision Date February 13, 2001
Days to Decision 81 days
Submission Type Abbreviated
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 110d · This submission: 81d
Pathway characteristics
Standards-based clearance path.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 191
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K003638.
VENTURI PHACO PACK
K033653 · Bausch & Lomb, Inc. · Dec 2003
INFINITI
K021566 · Alcon Laboratories, Inc. · Jul 2002
SURGE-FREE ASPIRATION ADAPTER
K020734 · Staar Surgical Co. · May 2002
OCUSYSTEM ART ADVANTAGE, MODEL 995
K991852 · Surgical Design Corp. · Jul 1999
FIBRA-SONICS PHACO III OR IIIP FRAGMENTATION SYSTEM
K984143 · Fibra Sonics, Inc. · Feb 1999
THE WAVE DIGITAL PHACO SYSTEM
K981989 · Circuit Tree · Aug 1998